Left Ventricular Wall Stress Is Sensitive Marker of Hypertrophic Cardiomyopathy With Preserved Ejection Fraction

Xiaodan Zhao1, Ru-San Tan1,2, Hak-Chiaw Tang1,2

  • 1National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore.

Insights

Hypertrophic cardiomyopathy (HCM) diagnosis can be improved using a novel wall stress index derived from cardiac MRI. This index, incorporating regional wall curvature, accurately differentiates HCM patients from controls.

Area of Science:

  • Cardiovascular Imaging
  • Biomedical Engineering
  • Medical Diagnostics

Background:

  • Hypertrophic cardiomyopathy (HCM) is characterized by altered myocardial mechanics and increased ventricular wall thickness.
  • Current diagnostic methods for HCM primarily rely on measuring myocardium wall thickness.

Purpose of the Study:

  • To quantify regional left ventricular (LV) shape, wall stress, and deformation using cardiac MRI.
  • To establish superior diagnostic measures for differentiating HCM patients from healthy controls.

Main Methods:

  • Cardiac MRI scans were acquired for 19 HCM patients and 19 controls.
  • 3D LV geometrical models were reconstructed to compute regional parameters including wall thickness, curvedness, wall stress, area strain, and ejection fraction.
  • A multivariate stepwise selection algorithm identified predictors of HCM.

Main Results:

  • Significant differences in all regional parameters were observed between HCM patients and controls (P < 0.001).
  • HCM patients exhibited greater wall thickness, particularly in septal regions.
  • The end-diastolic wall stress index (σ ) was the strongest independent predictor of HCM (AUC = 0.947), with 94.7% sensitivity and specificity at a cutoff of < 1.64.

Conclusions:

  • The end-diastolic wall stress index, integrating regional wall curvature, serves as a sensitive biomarker for HCM diagnosis.
  • This index shows potential utility in both diagnostic and therapeutic assessments of HCM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
526
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
589
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
587
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
470
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
619
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
365